Propanc Biopharma, Inc. Quarterly Operating Income (Loss) in USD from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Propanc Biopharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q4 2010 to Q3 2024.
  • Propanc Biopharma, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$291K, a 30.3% increase year-over-year.
  • Propanc Biopharma, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$1.41M, a 13% increase year-over-year.
  • Propanc Biopharma, Inc. annual Operating Income (Loss) for 2024 was -$1.54M, a 13.5% increase from 2023.
  • Propanc Biopharma, Inc. annual Operating Income (Loss) for 2023 was -$1.78M, a 10.8% increase from 2022.
  • Propanc Biopharma, Inc. annual Operating Income (Loss) for 2022 was -$1.99M, a 9.86% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$1.41M -$291K +$126K +30.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$1.54M -$260K -$50.3K -24% Apr 1, 2024 Jun 30, 2024 10-K 2024-09-30
Q1 2024 -$1.49M -$421K -$34.7K -8.97% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$1.45M -$438K +$170K +28% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-20
Q3 2023 -$1.62M -$417K +$156K +27.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$1.78M -$210K +$390K +65% Apr 1, 2023 Jun 30, 2023 10-K 2024-09-30
Q1 2023 -$2.17M -$386K +$116K +23.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$2.28M -$608K -$205K -50.7% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-20
Q3 2022 -$2.08M -$573K -$86.8K -17.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$1.99M -$599K +$128K +17.6% Apr 1, 2022 Jun 30, 2022 10-K 2023-09-28
Q1 2022 -$2.12M -$502K -$74.2K -17.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$2.04M -$403K -$129K -47.2% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-10
Q3 2021 -$1.92M -$486K -$103K -26.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$1.81M -$727K -$133K -22.4% Apr 1, 2021 Jun 30, 2021 10-K 2022-09-28
Q1 2021 -$1.68M -$428K +$179K +29.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$1.86M -$274K +$1.11M +80.2% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q3 2020 -$2.97M -$383K +$526K +57.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$3.49M -$594K +$242K +29% Apr 1, 2020 Jun 30, 2020 10-K 2021-09-28
Q1 2020 -$3.74M -$607K -$35.4K -6.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$3.7M -$1.38M -$626K -82.6% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-12
Q3 2019 -$3.08M -$909K -$461K -103% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$2.61M -$836K -$325K -63.4% Apr 1, 2019 Jun 30, 2019 10-K 2020-10-01
Q1 2019 -$2.29M -$572K +$235K +29.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$2.53M -$758K +$679K +47.3% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-14
Q3 2018 -$3.2M -$449K +$755K +62.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$3.96M -$512K +$598K +53.9% Apr 1, 2018 Jun 30, 2018 10-K 2019-10-15
Q1 2018 -$4.56M -$807K +$740K +47.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$5.3M -$1.44M +$472K +24.7% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-14
Q3 2017 -$5.77M -$1.2M -$29.7K -2.53% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$5.74M -$1.11M +$2.35M +67.9% Apr 1, 2017 Jun 30, 2017 10-K 2018-09-17
Q1 2017 -$8.09M -$1.55M -$257K -19.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$7.83M -$1.91M -$765K -66.9% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-09
Q3 2016 -$7.06M -$1.17M -$167K -16.6% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$6.9M -$3.46M -$2.75M -393% Apr 1, 2016 Jun 30, 2016 10-K 2017-09-28
Q1 2016 -$4.14M -$1.29M -$774K -150% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 -$3.37M -$1.14M -$894K -359% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-14
Q3 2015 -$2.47M -$1.01M -$769K -323% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$1.71M -$701K -$579K -471% Apr 1, 2015 Jun 30, 2015 10-K 2016-09-28
Q1 2015 -$1.13M -$517K -$412K -395% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 -$715K -$249K -$24K -10.6% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-16
Q3 2014 -$691K -$238K +$70.4K +22.8% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 -$761K -$123K +$66.8K +35.2% Apr 1, 2014 Jun 30, 2014 10-K 2015-09-30
Q1 2014 -$828K -$104K +$125K +54.5% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 -$953K -$225K +$221K +49.6% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-17
Q3 2013 -$1.17M -$309K +$187K +37.8% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-19
Q2 2013 -$1.36M -$190K +$2.35M +92.5% Apr 1, 2013 Jun 30, 2013 10-K 2014-10-14
Q1 2013 -$3.71M -$229K +$2.87M +92.6% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-20
Q4 2012 -$6.58M -$447K +$2.43M +84.5% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-14
Q3 2012 -$9.01M -$496K +$2.58M +83.9% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$11.6M -$2.54M Apr 1, 2012 Jun 30, 2012 10-K 2013-10-15
Q1 2012 -$3.09M -$2.59M -509% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-20
Q4 2011 -$2.88M -$2.39M -485% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-20
Q3 2011 -$3.07M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-19
Q1 2011 -$508K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-21
Q4 2010 -$492K Oct 1, 2010 Dec 31, 2010 10-Q/A 2012-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.